SSG
EOLS icon

Summit Securities Group’s Evolus EOLS Stock Holding History

Summit Securities Group’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,429
Closed -$14.1K – 1219
2026
Q1 		$14.1K Buy
3,429
+2,974
+654% +$14.4K ﹤0.01% 597
2025
Q4 		$3.03K Buy
+455
New +$3.08K ﹤0.01% 946

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Summit Securities Group's EOLS Position: Q2 2026 in Review

Summit Securities Group sold out of Evolus (EOLS) in Q2 2026, closing a stake of 3,429 shares — an estimated $14.1K sold.

Summit Securities Group first reported a position in EOLS in Q4 2025 and held it in 2 quarters. The position peaked at $14.1K in Q1 2026. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Summit Securities Group reported no remaining Evolus position as of Q2 2026 after selling out during the quarter.
  • Summit Securities Group sold 3,429 Evolus shares in Q2 2026, an estimated $14.1K.
  • Summit Securities Group first reported a position in Evolus in Q4 2025 and held it in 2 quarters.
  • Summit Securities Group's Evolus position peaked at $14.1K in Q1 2026.
  • 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.